FXR overexpression reduced the cholesterol contents in human TSGH8301 and T24 bladder cancer cells, and this effect may depend on the inhibition of the PI3K/AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and urinary bladder carcinoma.